MDS assessments incorrectly coded aspirin as an anticoagulant
Summary
The facility failed to document complete and accurate MDS assessments for seven residents, including four residents in the sample and three residents outside the sample. The deficiency centered on Section N0415, where aspirin was repeatedly coded as an anticoagulant instead of an antiplatelet. The facility policy required MDS data to accurately reflect the resident’s status and be coded according to RAI Manual guidelines, and the RAI Manual stated that aspirin is an antiplatelet and should not be coded as an anticoagulant. Resident #1 had diagnoses of MS, dementia, and anxiety disorder, and the POS showed aspirin 81 mg daily for preventative use with no anticoagulant order. However, the significant change MDS coded N0415E1 as yes for anticoagulant and N0415I1 as no for antiplatelet. Resident #2 had diagnoses of cerebral palsy, CKD, and PVD, and the POS showed aspirin 81 mg daily with no anticoagulant order, yet multiple MDS assessments coded aspirin as an anticoagulant and did not code it as an antiplatelet. Resident #3 had diagnoses of heart disease, aortic and mitral valve insufficiency, and CKD; the POS showed aspirin daily and a prior Eliquis order that had been discontinued, but quarterly and significant change MDS assessments still coded anticoagulant use and did not code aspirin as an antiplatelet. Resident #6 had diagnoses of HTN, hyperlipidemia, cardiac murmur, and chronic ischemic heart disease, with an aspirin order for preventative use, but the significant change MDS coded anticoagulant use and did not code antiplatelet use. Resident #30 had diagnoses of stroke, aphasia, and heart disease; the POS showed aspirin daily and a prior heparin order that had been discontinued, but the MDS assessments continued to code anticoagulant use. Resident #38 had diagnoses of CKD, atherosclerotic heart disease, atherosclerosis of the aorta, and an artificial heart valve, and Resident #48 had diagnoses of atherosclerosis of the aorta, muscle weakness, and carotid artery stenosis; both had aspirin orders and their MDS assessments coded anticoagulant use instead of antiplatelet use. During interview, the MDS Coordinator stated she had been coding aspirin as an anticoagulant and believed she had become confused when antiplatelet was added to the MDS assessment.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.